https://www.optimumcomms.com/wp-content/uploads/2024/11/Infinitopes_Logo_300x180px-80x80Web_Logos.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2025-03-20 08:30:582025-03-25 14:34:24Infinitopes Strengthens Board with Two Biotech Leaders to Advance Precision Immunotherapies into the Clinic
https://www.optimumcomms.com/wp-content/uploads/2024/11/Infinitopes_Logo_300x180px-80x80Web_Logos.png
180
300
optimus
https://www.optimumcomms.com/wp-content/uploads/2024/10/Optimum_Logo-white.svg
optimus2025-03-20 08:30:582025-03-25 14:34:24Infinitopes Strengthens Board with Two Biotech Leaders to Advance Precision Immunotherapies into the Clinic
BioClec launches with backing from Sofinnova Partners to pioneer breakthrough Alzheimer’s Therapies
Co-founded by Dr. Marco Colonna, a global expert in neuroimmunology…

Forth Therapeutics launches with backing from Sofinnova Partners to revolutionize fibrosis treatments
Cutting-edge research from Professor Neil Henderson at the…

Sofinnova Partners and Gustave Roussy launch first biotech company through Strategic Partnership
Signadori Bio, a novel cell therapy platform, emerges from…

Sofinnova Partners exceeds target with €165M biotech acceleration fund, Europe’s largest, with strong Pharma support
Biovelocita II attracts robust support from leading pharmaceutical…

iOnctura strengthens leadership with appointments of Chief Business Officer and Board Chair
Elizabeth Holt, with a proven track record of forging successful…

SpliceBio Announces First Patient Dosed in Phase 1/2 ASTRA Study of SB-007, a Dual-AAV Gene Therapy for Stargardt Disease
SB-007 addresses the root cause of Stargardt disease with…

Heidelberg Pharma Amends Royalty Financing with HealthCare Royalty
HealthCare Royalty and Heidelberg Pharma amend royalty financing…

Pioneering plant microbiome research: Julia Vorholt receives 2025 Novonesis Biotechnology Prize from the Novo Nordisk Foundation
Copenhagen, Denmark – 13 March 2025: Professor Julia Vorholt’s…

Xeltis expands Medical Advisory Board with World Leading Experts in Clinical Nephrology
Leading nephrologists Dr. An De Vriese and Dr. Monnie Wasse…

Sofinnova Partners raises €1.2 billion to fuel the next wave of life sciences innovation
Leading European venture capital firm exceeds €4 billion in…

Novo Holdings and TA Associates partner with Biocomposites to drive next chapter of its growth
Additional investment and resources will accelerate Biocomposites’…

Domain Therapeutics to present and participate at major global healthcare conferences, March to June 2025
Domain’s leadership will highlight advancements in its key…

Experienced Industry Leader Tom Arnold Appointed as Chief Executive Officer of ViCentra
Experienced MedTech leader to scale manufacturing, drive…

Ottimo Pharma Strengthens Leadership Team with Senior Appointments
Robert Tighe appointed as Senior Vice President of Preclinical…

Unravelling the infection enigma: Jean-Laurent Casanova’s pioneering genetic discoveries earn him the 2025 Novo Nordisk Prize
For decades, scientists believed that infections were determined…
We’d love to hear from you
For more information about Optimum Strategic Communications, please get in touch.
Optimum Strategic Communications’ specialist team has an in-depth understanding of how to communicate complex science to investors and corporate stakeholders. Optimum helps life science companies on their journey as they grow and has been trusted by hundreds of healthcare clients from around the world, both public and private, large and small.
Locations
- London
- Amsterdam
- Stockholm
- Zurich
- New York